manilatimes4h
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...
'Large IT firms have been big disappointments': CIO blasts India's tech giants for ignoring R&D
Mihir Vora's remarks came after Nilesh Jasani, Founder of GenInnov Funds, pointed out striking advancements in AI in China.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Daily15h
AIIMS New Delhi Invites Applications for PhD Programme January 2025 Session, check all admission details
New Delhi is inviting online applications from candidates willing to take admission to PhD Programme for the January 2025 ...
The New York Times9h
New York Times - Top Stories
Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 22 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...